Is Low-dose Aspirin a Useful Adjuvant Therapy in the Treatment of NIDDM?
β Scribed by Mubarak, Ahmed A.S.
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 26 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0742-3071
No coin nor oath required. For personal study only.
β¦ Synopsis
between 5.5 and 10 mmol l Οͺ1 . In May There is increasing evidence supporting the use of aspirin in patients with non-1996, fasting blood glucose was
π SIMILAR VOLUMES
To determine the optimal treatment volume in Hodgkin's disease patients undergoing high-dose chemotherapy (HDCT) and radiation therapy (RT), failure sites were reviewed in 56 patients. Twenty-one (38%) received involved-field RT (IFRT) before or after HDCT encompassing sites of prior disease. Failur
Infection with the human immunodeficiency virus (HIV) frequently is complicated with thrombocytopenia (HIV-Thr) during all stages of the infection. The treatments for autoimmune thrombocytopenic purpura (ITP) are used in HIV-Thr; however, their effects upon the immune status of patients with acquire
A clinical investigation was conducted of therapy of patients with acute pneumonia using a new antioxidant diquertin, whose primary component is a bioflavonoid, dihydroquercetin. It was demonstrated that patients with acute pneumonia receiving diquertin in an adjuvant therapy had a faster recovery f